Free Trial

TELA Bio (TELA) SEC Filings & 10K Form

TELA Bio logo
$1.85 -0.02 (-1.07%)
As of 10:58 AM Eastern

Recent TELA Bio SEC Filings

DateFilerForm TypeView
06/02/2025
7:30 AM
TELA Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025
3:15 PM
Burgess Vincent J (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
3:17 PM
Blizard Jeffrey (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
3:17 PM
Azarbarzin Kurt (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
3:18 PM
O'Brien Federica F. (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
3:18 PM
EVANS DOUGLAS G (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
3:00 PM
NORTH RUN CAPITAL, LP (Filed by)
TELA Bio (Subject)
Form SCHEDULE 13G
05/08/2025
3:30 PM
TELA Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:57 AM
HIRSCHMAN ORIN (Filed by)
TELA Bio (Subject)
Form SCHEDULE 13G/A
04/17/2025
3:20 PM
TELA Bio (Filer)
Form DEFA14A
04/17/2025
3:29 PM
TELA Bio (Filer)
Form ARS
04/02/2025
3:44 PM
Firestone Gregory A. (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:45 PM
KOBLISH ANTONY (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:46 PM
Smeykal Megan (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:49 PM
Talmo Paul (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
6:15 AM
TELA Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:35 PM
TELA Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2025
11:07 AM
Stonepine Capital Management, LLC (Filed by)
TELA Bio (Subject)
Form SCHEDULE 13G/A
02/12/2025
2:54 PM
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
TELA Bio (Subject)
Form SCHEDULE 13G
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
TELA Bio (Subject)
Form SCHEDULE 13G
11/08/2024
3:05 PM
TELA Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
4:12 PM
Stonepine Capital Management, LLC (Filed by)
TELA Bio (Subject)
Form SC 13G
10/28/2024
3:06 PM
EW HEALTHCARE PARTNERS FUND 2, L.P. (Filed by)
TELA Bio (Subject)
Form SC 13G/A
10/25/2024
3:24 PM
ORBIMED ADVISORS LLC (Filed by)
TELA Bio (Subject)
Form SC 13D/A
10/24/2024
3:24 PM
Firestone Gregory A. (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2024
3:25 PM
KOBLISH ANTONY (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2024
3:25 PM
Talmo Paul (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2024
3:26 PM
Cuca Roberto (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
4:15 PM
TELA Bio (Filer)
Form 424B5
10/23/2024
4:16 PM
TELA Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
3:01 PM
TELA Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
3:06 PM
TELA Bio (Filer)
Form 424B5
10/01/2024
4:35 PM
ORBIMED ADVISORS LLC (Filed by)
TELA Bio (Subject)
Form SC 13D/A
08/13/2024
3:20 PM
TELA Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:15 PM
TELA Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:35 PM
Firestone Gregory A. (Reporting)
TELA Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
4:50 PM
GROW FUNDS, LLC. (Filed by)
TELA Bio (Subject)
Form SCHEDULE 13G
07/22/2024
2:20 PM
LYTTON LAURENCE W (Filed by)
TELA Bio (Subject)
Form SC 13G
06/28/2024
4:37 PM
ORBIMED ADVISORS LLC (Reporting)
TELA Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TELA) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners